Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.

Yvonne Collins, Dong Feng Tan, Tanja Pejovic, Gil Mor, Feng Qian, Thomas Rutherford, Ram Varma, Devin McQuaid, Deborah Driscoll, Ming Jiang, George Deeb, Shashikant Lele, Norma Nowak, Kunle Odunsi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

To identify changes in gene expression in serous epithelial ovarian cancers (SEOC), we utilized cDNA microarrays consisting of 2382 genes with cancer related properties to analyze tumors from 20 patients with defined clinical out-comes. The significance analysis of microarrays method was used to determine differentially expressed genes, leading to the identification of 134 up-regulated and 231 down-regulated genes overall. By increasing the stringency of the statistical selection criteria, 41 over-expressed and 51 under-expressed genes were identified. The median duration of follow-up of the 20 patients was 16.8 months with a median progression free survival of 7.0 months. We found 11 genes that were differentially over-expressed in patients with recurrent disease, and 3 genes (homo sapiens mRNA for Ins P3 5-phophatase, lipoma HMGIC fusion partner-like 2 and CD63 melanoma 1 antigen) in patients who were dead of disease. Subsequently, we examined the distribution of the differentially expressed genes in the cDNA library database from adult human tumor and normal tissues using the DigiNorthern method to identify a subset of genes with relatively restricted tissue distribution. Finally, protein expression of 5 selected genes were further examined using immunohistochemistry applied on a tissue microarray prepared from an independent panel of 93 SEOC tissues. The results provided validation for 2 under-expressed genes (E2F transcription factor 5 and CK14) and 3 over-expressed genes (Bcl2-like 1, COX-2, CD63). Our study demonstrates differential gene expression in clinically distinct groups of SEOC using cDNA microarray. These genes may potentially be useful as biomarkers and/or targets for therapeutic intervention.

Original languageEnglish (US)
Pages (from-to)43-53
Number of pages11
JournalInternational Journal of Molecular Medicine
Volume14
Issue number1
StatePublished - Jul 2004
Externally publishedYes

Fingerprint

Oligonucleotide Array Sequence Analysis
Carcinoma
Genes
E2F5 Transcription Factor
E2F3 Transcription Factor
CD63 Antigen
Melanoma-Specific Antigens
Gene Expression
Lipoma
Neoplasm Genes
Tissue Distribution
Microarray Analysis
Gene Library
Patient Selection
Disease-Free Survival
Neoplasms
Biomarkers
Immunohistochemistry
Databases
Messenger RNA

ASJC Scopus subject areas

  • Genetics

Cite this

Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray. / Collins, Yvonne; Tan, Dong Feng; Pejovic, Tanja; Mor, Gil; Qian, Feng; Rutherford, Thomas; Varma, Ram; McQuaid, Devin; Driscoll, Deborah; Jiang, Ming; Deeb, George; Lele, Shashikant; Nowak, Norma; Odunsi, Kunle.

In: International Journal of Molecular Medicine, Vol. 14, No. 1, 07.2004, p. 43-53.

Research output: Contribution to journalArticle

Collins, Y, Tan, DF, Pejovic, T, Mor, G, Qian, F, Rutherford, T, Varma, R, McQuaid, D, Driscoll, D, Jiang, M, Deeb, G, Lele, S, Nowak, N & Odunsi, K 2004, 'Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.', International Journal of Molecular Medicine, vol. 14, no. 1, pp. 43-53.
Collins, Yvonne ; Tan, Dong Feng ; Pejovic, Tanja ; Mor, Gil ; Qian, Feng ; Rutherford, Thomas ; Varma, Ram ; McQuaid, Devin ; Driscoll, Deborah ; Jiang, Ming ; Deeb, George ; Lele, Shashikant ; Nowak, Norma ; Odunsi, Kunle. / Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray. In: International Journal of Molecular Medicine. 2004 ; Vol. 14, No. 1. pp. 43-53.
@article{4c5b6321e4cb4ccd9a0a7cbb3f4a620a,
title = "Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.",
abstract = "To identify changes in gene expression in serous epithelial ovarian cancers (SEOC), we utilized cDNA microarrays consisting of 2382 genes with cancer related properties to analyze tumors from 20 patients with defined clinical out-comes. The significance analysis of microarrays method was used to determine differentially expressed genes, leading to the identification of 134 up-regulated and 231 down-regulated genes overall. By increasing the stringency of the statistical selection criteria, 41 over-expressed and 51 under-expressed genes were identified. The median duration of follow-up of the 20 patients was 16.8 months with a median progression free survival of 7.0 months. We found 11 genes that were differentially over-expressed in patients with recurrent disease, and 3 genes (homo sapiens mRNA for Ins P3 5-phophatase, lipoma HMGIC fusion partner-like 2 and CD63 melanoma 1 antigen) in patients who were dead of disease. Subsequently, we examined the distribution of the differentially expressed genes in the cDNA library database from adult human tumor and normal tissues using the DigiNorthern method to identify a subset of genes with relatively restricted tissue distribution. Finally, protein expression of 5 selected genes were further examined using immunohistochemistry applied on a tissue microarray prepared from an independent panel of 93 SEOC tissues. The results provided validation for 2 under-expressed genes (E2F transcription factor 5 and CK14) and 3 over-expressed genes (Bcl2-like 1, COX-2, CD63). Our study demonstrates differential gene expression in clinically distinct groups of SEOC using cDNA microarray. These genes may potentially be useful as biomarkers and/or targets for therapeutic intervention.",
author = "Yvonne Collins and Tan, {Dong Feng} and Tanja Pejovic and Gil Mor and Feng Qian and Thomas Rutherford and Ram Varma and Devin McQuaid and Deborah Driscoll and Ming Jiang and George Deeb and Shashikant Lele and Norma Nowak and Kunle Odunsi",
year = "2004",
month = "7",
language = "English (US)",
volume = "14",
pages = "43--53",
journal = "International Journal of Molecular Medicine",
issn = "1107-3756",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Identification of differentially expressed genes in clinically distinct groups of serous ovarian carcinomas using cDNA microarray.

AU - Collins, Yvonne

AU - Tan, Dong Feng

AU - Pejovic, Tanja

AU - Mor, Gil

AU - Qian, Feng

AU - Rutherford, Thomas

AU - Varma, Ram

AU - McQuaid, Devin

AU - Driscoll, Deborah

AU - Jiang, Ming

AU - Deeb, George

AU - Lele, Shashikant

AU - Nowak, Norma

AU - Odunsi, Kunle

PY - 2004/7

Y1 - 2004/7

N2 - To identify changes in gene expression in serous epithelial ovarian cancers (SEOC), we utilized cDNA microarrays consisting of 2382 genes with cancer related properties to analyze tumors from 20 patients with defined clinical out-comes. The significance analysis of microarrays method was used to determine differentially expressed genes, leading to the identification of 134 up-regulated and 231 down-regulated genes overall. By increasing the stringency of the statistical selection criteria, 41 over-expressed and 51 under-expressed genes were identified. The median duration of follow-up of the 20 patients was 16.8 months with a median progression free survival of 7.0 months. We found 11 genes that were differentially over-expressed in patients with recurrent disease, and 3 genes (homo sapiens mRNA for Ins P3 5-phophatase, lipoma HMGIC fusion partner-like 2 and CD63 melanoma 1 antigen) in patients who were dead of disease. Subsequently, we examined the distribution of the differentially expressed genes in the cDNA library database from adult human tumor and normal tissues using the DigiNorthern method to identify a subset of genes with relatively restricted tissue distribution. Finally, protein expression of 5 selected genes were further examined using immunohistochemistry applied on a tissue microarray prepared from an independent panel of 93 SEOC tissues. The results provided validation for 2 under-expressed genes (E2F transcription factor 5 and CK14) and 3 over-expressed genes (Bcl2-like 1, COX-2, CD63). Our study demonstrates differential gene expression in clinically distinct groups of SEOC using cDNA microarray. These genes may potentially be useful as biomarkers and/or targets for therapeutic intervention.

AB - To identify changes in gene expression in serous epithelial ovarian cancers (SEOC), we utilized cDNA microarrays consisting of 2382 genes with cancer related properties to analyze tumors from 20 patients with defined clinical out-comes. The significance analysis of microarrays method was used to determine differentially expressed genes, leading to the identification of 134 up-regulated and 231 down-regulated genes overall. By increasing the stringency of the statistical selection criteria, 41 over-expressed and 51 under-expressed genes were identified. The median duration of follow-up of the 20 patients was 16.8 months with a median progression free survival of 7.0 months. We found 11 genes that were differentially over-expressed in patients with recurrent disease, and 3 genes (homo sapiens mRNA for Ins P3 5-phophatase, lipoma HMGIC fusion partner-like 2 and CD63 melanoma 1 antigen) in patients who were dead of disease. Subsequently, we examined the distribution of the differentially expressed genes in the cDNA library database from adult human tumor and normal tissues using the DigiNorthern method to identify a subset of genes with relatively restricted tissue distribution. Finally, protein expression of 5 selected genes were further examined using immunohistochemistry applied on a tissue microarray prepared from an independent panel of 93 SEOC tissues. The results provided validation for 2 under-expressed genes (E2F transcription factor 5 and CK14) and 3 over-expressed genes (Bcl2-like 1, COX-2, CD63). Our study demonstrates differential gene expression in clinically distinct groups of SEOC using cDNA microarray. These genes may potentially be useful as biomarkers and/or targets for therapeutic intervention.

UR - http://www.scopus.com/inward/record.url?scp=14644411317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14644411317&partnerID=8YFLogxK

M3 - Article

C2 - 15202015

AN - SCOPUS:14644411317

VL - 14

SP - 43

EP - 53

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 1

ER -